Group 1 - The report highlights that the new consumption sector performed well, with service consumption policies expected to continue catalyzing growth in 2026 [2][27] - In 2025, the overall performance of the optional consumption sector was weak, but sub-sectors like new consumption showed significant gains, particularly in the first half of the year [16][21] - The retail sales of consumer goods grew moderately, with service retail growth outpacing that of goods retail, indicating a shift towards service consumption [21][27] Group 2 - The tourism sector is expected to benefit from extended holiday periods and improved vacation policies, with companies like Trip.com and Tongcheng Travel being key focuses [3] - The hotel market is showing signs of recovery, with a narrowing decline in RevPAR and increasing leisure demand, highlighting companies like Jin Jiang Hotels and Huazhu Group [3] - The duty-free sector is experiencing a boost from new policies, particularly in Hainan, with a focus on high-end consumption recovery [3] Group 3 - The cosmetics industry saw a slight growth of 6.18% in 2025, with domestic brands continuing to gain market share [4][30] - The medical beauty market is projected to reach approximately 366.6 billion in 2025, with a K-shaped consumption differentiation emerging [4][30] - Innovations in core ingredients and the integration of biotechnology are driving brand growth in the cosmetics sector [4][36] Group 4 - The IP derivative market is expanding due to a flourishing supply of IP and commercial operations, with domestic policies expected to further mature the industry ecosystem [5] - Key players in the IP space include Shanghai Film, Light Media, and Pop Mart, with a focus on both domestic and international market expansion [5] Group 5 - The gold and jewelry sector saw a cumulative growth of 12.78% in retail sales from January to December, with a focus on brand premium capabilities and international expansion [6][9] - The rise of "self-wearing" scenarios is driving gold jewelry sales, with brands like Chao Hong Ji and Lao Pu Gold being highlighted for their international strategies [9]

Core Insights - The article highlights the significant advancements in China's medical aesthetics industry, particularly the achievements of a Shenzhen-based company in developing domestically produced ultrasound and radiofrequency medical devices that have received both NMPA and FDA certifications [1][2][3]. Group 1: Technological Breakthroughs - The first domestically produced ultrasound skin treatment device has received Class III certification, while the radiofrequency skin treatment device "Half Island Counterclockwise" is the first in China to obtain both NMPA and FDA approvals [1]. - The "Half Island Big Super Cannon" integrates various treatment handles and heads, enhancing treatment comfort and effectiveness, supported by clinical data showing an 82% effectiveness rate and 88% satisfaction rate from 204 cases [1]. - The radiofrequency microneedle device demonstrated a 96% effectiveness rate in scar improvement and a 98.75% patient satisfaction rate from 180 cases [1][2]. Group 2: Industry Evolution - Over the past 17 years, the company has transitioned from relying on foreign medical equipment to becoming a leader in the global medical aesthetics market, with a significant increase in R&D investment and patent applications [3]. - The company currently has a central R&D team of 180 members, with plans to increase the number of medical professionals to 65 by 2026, and has a notable share of global patent applications in the medical aesthetics sector [3]. - The company's ultrasound devices are now used in nearly 6,000 hospitals nationwide, and the radiofrequency microneedle has reached approximately 4,000 medical institutions, with user numbers projected to exceed 1 million by 2025 [3]. Group 3: Innovation Ecosystem - Shenzhen's innovation ecosystem has played a crucial role in the company's success, supported by policies, capital, and a rich clinical resource environment [4]. - The company has been recognized as a "national-level specialized and innovative small giant" and has received national-level intellectual property advantages, contributing to the growth of Shenzhen's high-end medical device industry [4]. - The company has published nearly 100 academic papers, with over 30 in SCI journals, and has participated in developing industry standards, promoting the standardization of the sector [4]. Group 4: Future Outlook - The year 2026 is anticipated to be pivotal for the medical aesthetics industry, focusing on compliance and high-quality development [7]. - The company emphasizes training for doctors and consumer education, with a rigorous certification system for device operation, ensuring standardized application of technology [7]. - The case reflects the broader trend of China's medical aesthetics industry evolving from imitation to innovation, aiming for international competitiveness [7].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][29]. Core Insights - The October CPI performance exceeded expectations, with a year-on-year increase of 0.2%, higher than the consensus forecast of -0.04%. The core CPI, excluding food and energy, rose by 1.2%, marking the highest increase since March 2024 [4][24]. - The implementation of the new duty-free policy in Hainan has led to a surge in tourism consumption, with duty-free shopping amounting to 506 million yuan from November 1 to 7, representing a year-on-year growth of 34.86% [5][27]. - Key events in the beauty care sector include Kimberly-Clark's acquisition of Kenvue, expected to complete in the second half of 2026, and Amorepacific's Q3 operating profit increasing by 41% [4][24]. Summary by Sections Market Performance - For the week of November 3 to November 7, the retail trade, social services, and beauty care sectors saw changes of +0.31%, +0.11%, and -3.10% respectively, ranking 17th, 19th, and 31st among 31 primary industries [15][17]. Key Industry Data and News - The beauty care sector is highlighted by Kimberly-Clark's acquisition of Kenvue and Amorepacific's significant profit increase. Additionally, new medical devices have received regulatory approval [4][24]. - In the travel sector, the number of domestic flights increased by 4.9% compared to 2019, with a total of approximately 101,000 flights executed in the week [5][24]. - The IP derivatives market is seeing growth, with significant sales expected from the film "Wang Wang Mountain" and new store openings in the toy sector [5][28]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzhibio, Marubi, Runben, Proya, Chaohongji, and Furuida within the beauty care and new consumption sectors [6][29].